Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin pharmacokinetics in critically ill patients undergoing hemodiafiltration
2010-024457-36Phase 4Active
- Sponsor
- Dr.Gerardo Aguilar Dr.Francisco Martà Hospital ClÃnico de Valencia Ser. AnestesiologÃa y Reanimación
- Start
- Feb 2011
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of anidulafungin in invasive candidiasis, sponsored by Dr.Gerardo Aguilar Dr.Francisco Martà Hospital ClÃnico de Valencia Ser. AnestesiologÃa y Reanimación. Primary endpoint: Pharmacokinetic profile of anidulafungin during hemodiafiltration. Started Feb 2011; status: active.
02
Drugs
anidulafungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on 2010-024457-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024457-36.